The Tak1-dependent effect of Traf6 on cardiac hypertrophy in vitro prompted us to evaluate whether the activation of Tak1 is responsible for Traf6-mediated cardiac hypertrophy in vivo. The gene discussed is MAP3K7; the disease is cardiac hypertrophy.